Multiplex Assay Kit for Tau Protein (MAPT) ,etc. by FLIA (Flow Luminescence Immunoassay)

DDPAC; FTDP-17; MAPTL; MSTD; MTBT1; MTBT2; PPND; Neurofibrillary tangle protein; Microtubule Associated Protein Tau; Paired helical filament-tau; G Protein Beta1/Gamma2 Subunit-Interacting Factor 1

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Tau Protein (MAPT) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Tau Protein (MAPT) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Tau Protein (MAPT) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Tau Protein (MAPT) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 97-104 101
EDTA plasma(n=5) 89-104 101
heparin plasma(n=5) 85-99 89

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Tau Protein (MAPT) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Tau Protein (MAPT) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Tau Protein (MAPT) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 98-105% 94-105% 82-98% 87-96%
EDTA plasma(n=5) 93-105% 95-102% 84-91% 79-101%
heparin plasma(n=5) 78-90% 88-96% 78-95% 91-104%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:MAPT) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Eur Rev Med Pharmacol Sci. Effect of etanercept and lithium chloride on preventing secondary tissue damage in rats with experimental diffuse severe brain injury Pubmed:24452937
Pediatria i Medycyna Rodzinna Wpływ omdlenia u młodocianych na stężenie białka tau w surowicy krwi b09f7df8-1e7d-4665-a2a5-bf54dae0cfe9
Acta Angiologica Serum microtubule associated protein tau and myelin basic protein as the potential markers of brain ischaemia-reperfusion injury in patients undergoing carotid endarterectomy AA.2016.0008
Journal of physiology and pharmacology THE PRESENCE OF TAU PROTEIN IN BLOOD AS A POTENTIAL PROGNOSTIC FACTOR IN STROKE PATIENTS pubmed:28011949
Acta Angiol Serum microtubule associated protein tau and myelin basic protein as the potential markers of brain ischaemia-reperfusion injury in patients undergoing carotid endarterectomy AA.2016.0008
Frontiers in Aging Neuroscience Differential hyperphosphorylation of tau-S199,-T231 and-S396 in organotypic brain slices of Alzheimer mice. A model to study early tau hyperphosphorylation using … Pubmed:29725295
Scientific Reports The potential role of serum tau protein (MAPT), neuronal cell adhesion molecule (NrCAM) and neprilysin (NEP) in neurodegenerative disorders development in …
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPB983Hu01 Recombinant Tau Protein (MAPT) Positive Control; Immunogen; SDS-PAGE; WB.
PAB983Hu01 Polyclonal Antibody to Tau Protein (MAPT) WB; IHC
RAB983Hu21 Recombinant Antibody to Tau Protein (MAPT) WB; IF; ICC; IHC; IP; FCM.
MAB983Hu23 Monoclonal Antibody to Tau Protein (MAPT) WB; IHC; ICC; IP.
MAB983Hu21 Monoclonal Antibody to Tau Protein (MAPT) WB; IHC; ICC; IP.
MAB983Hu22 Monoclonal Antibody to Tau Protein (MAPT) WB; IHC; ICC; IP.
SEB983Hu ELISA Kit for Tau Protein (MAPT) Enzyme-linked immunosorbent assay for Antigen Detection.
MEB983Hu Mini Samples ELISA Kit for Tau Protein (MAPT) Enzyme-linked immunosorbent assay for Antigen Detection.
HEB983Hu High Sensitive ELISA Kit for Tau Protein (MAPT) Enzyme-linked immunosorbent assay for Antigen Detection.
LMB983Hu Multiplex Assay Kit for Tau Protein (MAPT) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.
KSB983Hu01 ELISA Kit DIY Materials for Tau Protein (MAPT) Main materials for "Do It (ELISA Kit) Yourself".